Kesatuan Eropah - Finland - EMA (European Medicines Agency)

astrazeneca ab - fulvestrantti - rintojen kasvaimet - hormonaalisen hoidon, anti-estrogeenit - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. pre - tai huonomaineiset naiset, yhdistelmä-hoidon palbociclib olisi yhdistettävä luteinisoivan hormonin vapauttava hormoni (lhrh) - agonisteilla.

Kesatuan Eropah - Finland - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degareliksia - prostatiset kasvaimet - endokriinihoito - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Kesatuan Eropah - Finland - EMA (European Medicines Agency)

vanda pharmaceuticals netherlands b.v. - tasimelteon - unihäiriöt, sirkadian rytmi - psyykenlääkkeiden - hetlioz on tarkoitettu 24-tunnin nukahtamishäiriön (ei-24) hoitoon täysin sokeilla aikuisilla.

Kesatuan Eropah - Finland - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Kesatuan Eropah - Finland - EMA (European Medicines Agency)

amgen europe b.v. - adalimumabi - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosuppressantit - katso kohta 4. 1 tuoteselosteesta tuotetietoasiakirjassa.

Kesatuan Eropah - Finland - EMA (European Medicines Agency)

merck sharp dohme limited - vorapaxar-sulfaatti - sydäninfarkti - antitromboottiset aineet - zontivityis tarkoitettu vähentämään aterotromboottisia tapahtumia aikuisilla potilailla, joilla on ollut sydäninfarkti (mi)samanaikaisesti asetyylisalisyylihapon (asa) ja, tarvittaessa, klopidogreeli; tai - oireisen perifeerinen valtimosairaus(pad), samanaikaisesti asetyylisalisyylihapon (asa) tai, tarvittaessa, clopidogrel.

Finland - Finland - Fimea (Suomen lääkevirasto)

pfizer oy - donepezil hydrochloride - tabletti, kalvopäällysteinen - 5 mg - donepetsiili

Finland - Finland - Fimea (Suomen lääkevirasto)

pfizer oy - donepezil hydrochloride - tabletti, kalvopäällysteinen - 10 mg - donepetsiili

Finland - Finland - Fimea (Suomen lääkevirasto)

eli lilly finland oy ab - atomoxetini hydrochloridum - kapseli, kova - 5 mg - atomoksetiini

Finland - Finland - Fimea (Suomen lääkevirasto)

pfizer oy pfizer oy - donepezili hydrochloridum - tabletti, suussa hajoava - 5 mg - donepetsiili